Vascular Abnormalities in Essential Hypertension

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|17|28|3039-3044

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.17, Iss.28, 2011-09, pp. : 3039-3044

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Relationships of osteoprotegerin with albuminuria and asymmetric dimethylarginine in essential hypertension: integrating vascular dysfunction

By Tsioufis Costas   Aggelis Athanasios   Dimitriadis Kyriakos   Thomopoulos Costas   Kasiakogias Alexandros   Tzamou Vanessa   Kyvelou Stella-Maria   Mikhailidis Dimitri P.   Papademetriou Vasilios   Stefanadis Christodoulos  

Expert Opinion on Therapeutic Targets, Vol. 15, Iss. 12, 2011-12 ,pp. : 1347-1353

Informa Healthcare

Access to resources Recommend Favorite

Novel therapeutic strategies targeting vascular endothelium in essential hypertension

By Tousoulis Dimitris   Papageorgiou Nikolaos   Androulakis Emmanouil   Paroutoglou Kiriaki   Stefanadis Christodoulos  

Expert Opinion on Investigational Drugs, Vol. 19, Iss. 11, 2010-11 ,pp. : 1395-1412

Informa Healthcare

Access to resources Recommend Favorite

Comparison of the Effects of Nebivolol and Bisoprolol on Systemic Vascular Resistance in Patients with Essential Hypertension: -Blockade and Haemodynamics in Hypertension

By Brett S.  

Clinical Drug Investigation, Vol. 22, Iss. 6, 2002-06 ,pp. : 355-359

Adis International

Access to resources Recommend Favorite

Management of essential hypertension

By Terpening C.   Gums J.G.   Grauer K.  

Expert Opinion on Pharmacotherapy, Vol. 1, Iss. 1, 1999-11 ,pp. : 71-80

Informa Healthcare

Access to resources Recommend Favorite

Inflammation Markers in Essential Hypertension

By  

Medicinal Chemistry, Vol. 10, Iss. 7, 2014-11 ,pp. : 672-681

Bentham Science Publishers

Access to resources Recommend Favorite